Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02638909
Title Study of Oral Ceritinib in Patients With ALK-Activated Gastrointestinal Malignancies
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Criterium, Inc.
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
USC/Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
University of Colorado Cancer Center Aurora Colorado 80045 United States Details
Yale University, Yale Cancer Center New Haven Connecticut 06520 United States Details
Laura & Isaac Permutter Cancer Center at NYU Langone New York New York 10016 United States Details
The Ohio State University, James Cancer Hospital Columbus Ohio 43210 United States Details
Swedish Cancer Institute Seattle Washington 98104 United States Details
*Shaded cells indicate that there was no data available from for the field